Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

NCT01710709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

748

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I

Interventions

DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]